Magenta Therapeutics, Inc.MGTANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+7.1%
5Y CAGR+7.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+7.1%/yr
vs +37.4%/yr prior
5Y CAGR
+7.6%/yr
Consistent
Acceleration
-30.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$34.33M+37.4%
2024$24.99M-3.0%
2022$25.76M-7.8%
2021$27.93M-0.6%
2020$28.09M+18.2%
2019$23.76M+27.6%
2018$18.62M+137.9%
2017$7.83M+124.6%
2016$3.49M-